The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Volnukhin V.A.

Moscow Scientic and Practical Center of Dermatovenereology and Cosmetology, Moscow, Russia

Skin disease phototherapy. Part I: basic aspects of application (in Russian only)

Authors:

Volnukhin V.A.

More about the authors

Read: 30452 times


To cite this article:

Volnukhin VA. Skin disease phototherapy. Part I: basic aspects of application (in Russian only). Russian Journal of Clinical Dermatology and Venereology. 2018;17(6):78‑84. (In Russ.)
https://doi.org/10.17116/klinderma20181706178

Recommended articles:
Mechanism of action of various therapies for viti­ligo. Pharmacologist’s and dermatovenerologist’s perspective. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(6):734-741

References:

  1. Morison W. Psoralen ultraviolet A therapy in 2004. Photodermatol Photoimmunol Photomed. 2004;20(6):315-320. https://doi.org/10.1111/j.1600-0781.2004.00125.x
  2. Sivanesan S, Gattu S, Hong J, et al. Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks. J Am Acad Dermatol. 2009;61(5):793-798. https://doi.org/10.1016/j.jaad.2009.04.053
  3. Trautinger F, Eder J, Assaf C, et al. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome — Update 2017. Eur J Cancer. 2017;77:57-74. https://doi.org/10.1016/j.ejca.2017.02.027
  4. Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol. 1981;76(5):359-362. https://doi.org/10.1111/1523-1747.ep12520022
  5. Gambichler T, Terras S, Kreuter A. Treatment regimens, protocols, dosage, and indications for UVA1 phototherapy: facts and controversies. Clin Dermatol. 2013;31(4):438-454. https://doi.org/10.1016/j.clindermatol.2013.01.011
  6. Aubin F, Vigan M, Puzenat E, et al. Evaluation of a novel 308-nm monochromatic excimer light delivery system in dermatology: a pilot study in different chronic localized dermatoses. Br J Dermatol. 2005;152(1):99-103. https://doi.org/10.1111/j.1365-2133.2005.06320.x
  7. Beggs S, Short J, Rengifo-Pardo M, Ehrlich A. Applications of the excimer laser: a review. Dermatol Surg. 2015;41(11):1201-1211. https://doi.org/10.1097/dss.0000000000000485
  8. Wolff K. Side-effects of psoralen photochemotherapy (PUVA). Br J Dermatol. 1990;122:Suppl 36:117-125. https://doi.org/10.1111/j.1365-2133.1990.tb02889.x
  9. Laube S, George SA. Adverse effects with PUVA and UVB phototherapy. J Dermatolog Treat. 2001;12(2):101-105. https://doi.org/10.1080/095466301317085390
  10. Stern RS, Lunder EJ. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA): a metaanalysis. Arch. Dermatol. 1998;134:1582-1585. https://doi.org/10.1001/archderm.134.12.1582
  11. Stern RS; PUVA Follow up Study. The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol. 2001;44(5):755-761. https://doi.org/10.1067/mjd.2001.114576
  12. Malanos D, Stern RS. Psoralen plus ultraviolet A does not increase the risk of cataracts: a 25-year prospective study. J Am Acad Dermatol. 2007;57(2):231-237. https://doi.org/10.1016/j.jaad.2007.04.027

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.